The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - Celgene; Janssen
Evaluation of minimal residual disease in relapsed/refractory multiple myeloma patients treated with venetoclax or placebo in combination with bortezomib and dexamethasone: BELLINI study analyses.
 
Philippe Moreau
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Takeda
 
Simon J. Harrison
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie
 
Michele Cavo
No Relationships to Disclose
 
Javier de La Rubia
Expert Testimony - Amgen; Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Janssen
 
Rakesh Popat
Honoraria - Celgene; GlaxoSmithKline; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Celgene; GlaxoSmithKline; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Takeda
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen-Cilag; Takeda
Speakers' Bureau - Amgen; BMS Brazil; Celgene; Janssen-Cilag; Takeda
 
Hans Salwender
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Sanofi; Takeda
 
Kenshi Suzuki
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Ono Pharmaceutical; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene
 
Inho Kim
No Relationships to Disclose
 
Andrew Spencer
Honoraria - Abbvie; Amgen; Celgene; Haemalogix; Janssen; Sanofi; Secura Bio; SERVIER; Specialised Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Haemalogix; Janssen; Sanofi; Secura Bio; SERVIER; Specialised Therapeutics; Takeda
Speakers' Bureau - Celgene; Takeda
Research Funding - Abbvie; Amgen; Celgene; Janssen; Takeda
 
Michael O'Dwyer
Leadership - Onkimmune
Stock and Other Ownership Interests - Onkimmune
Consulting or Advisory Role - Abbvie; Janssen
Research Funding - Bristol-Myers Squibb; GlycoMimetics; Janssen; Onkimmune
 
Wan-Jen Hong
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Muhammad Jalaluddin
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Xiaoqing Yang
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
James Michael Pauff
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Paulo Cesar Maciag
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jeremy A. Ross
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)